Nafamostat Mesylate for Treatment of COVID-19 in Hospitalised Patients: A Structured, Narrative Review María Patricia Hernández-MitreSteven Y. C. TongJason A. Roberts Review Article Open access 30 August 2022 Pages: 1331 - 1343
Clinical Pharmacokinetic Monitoring of Free Valproic Acid Levels: A Systematic Review Kevin LinVivien F. S. CaoKaren Dahri Systematic Review 30 August 2022 Pages: 1345 - 1363
Altered Bioavailability and Pharmacokinetics in Crohn’s Disease: Capturing Systems Parameters for PBPK to Assist with Predicting the Fate of Orally Administered Drugs Sarah AlrubiaJialin MaoAmin Rostami-Hodjegan Systematic Review Open access 03 September 2022 Pages: 1365 - 1392
Population Pharmacokinetics of Asciminib in Tyrosine Kinase Inhibitor-Treated Patients with Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic and Acute Phases Ying Fei LiFrancois Pierre CombesYu-Yun Ho Original Research Article 28 June 2022 Pages: 1393 - 1403
Single-Dose Pharmacokinetics of Milvexian in Participants with Normal Renal Function and Participants with Moderate or Severe Renal Impairment Vidya PereraGrigor AbelianBindu Murthy Original Research Article Open access 30 July 2022 Pages: 1405 - 1416
Evaluation of Safety and Clinically Relevant Drug–Drug Interactions with Tucatinib in Healthy Volunteers Ariel Topletz-EricksonAnthony LeeChristopher J. Endres Original Research Article Open access 06 August 2022 Pages: 1417 - 1426
Prediction of Tissue Exposures of Meropenem, Colistin, and Sulbactam in Pediatrics Using Physiologically Based Pharmacokinetic Modeling Shixing ZhuJiayuan ZhangSherwin K. B. Sy Original Research Article 10 August 2022 Pages: 1427 - 1441
Daptomycin Physiology-Based Pharmacokinetic Modeling to Predict Drug Exposure and Pharmacodynamics in Skin and Bone Tissues Romain GarreauDamien MontangeSylvain Goutelle Original Research Article 16 August 2022 Pages: 1443 - 1456
Pharmacokinetic/Pharmacodynamic Evaluation of the Dipeptidyl Peptidase 1 Inhibitor Brensocatib for Non-cystic Fibrosis Bronchiectasis James D. ChalmersHelen UsanskyKevin C. Mange Original Research Article Open access 25 July 2022 Pages: 1457 - 1469
Influence of Darolutamide on Cabazitaxel Systemic Exposure Stefan A. J. BuckNiels A. D. GuchelaarRon H. J. Mathijssen Research Letter 27 July 2022 Pages: 1471 - 1473
Correction to: Population Pharmacokinetics of Asciminib in Tyrosine Kinase Inhibitor-Treated Patients with Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic and Acute Phases Ying Fei LiFrancois Pierre CombesYu-Yun Ho Correction 17 August 2022 Pages: 1475 - 1476